{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:42:34Z","timestamp":1781808154977,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.canlet.2009.09.022","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T10:59:02Z","timestamp":1258109942000},"page":"67-75","source":"Crossref","is-referenced-by-count":35,"title":["Selective targeting of HPV-16 E6\/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo"],"prefix":"10.1016","volume":"291","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2009.09.022_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2009.09.022_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/01.AOG.0000215986.48590.79","article-title":"Cervical cancer","volume":"107","author":"Moore","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2009.09.022_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.39337.615197.80","article-title":"Diagnosis and management of cervical cancer","volume":"335","author":"Petignat","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2009.09.022_bib4","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.ygyno.2007.07.004","article-title":"Chemotherapy for recurrent cervical cancer","volume":"107","author":"Cadron","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2009.09.022_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.canlet.2009.09.022_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/78638","article-title":"A controlled trial of intratumoral ONYX-015 a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"6","author":"Khuri","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2009.09.022_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.cgt.7700455","article-title":"Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus","volume":"9","author":"Habib","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/10430349950018652","article-title":"Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene","volume":"10","author":"Hay","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2009.09.022_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"Fueyo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.09.022_bib11","first-page":"798","article-title":"A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer","volume":"6","author":"Ganly","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.022_bib12","first-page":"5453","article-title":"CV706 a prostate cancer-specific adenovirus variant in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity","volume":"61","author":"Chen","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.022_bib13","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1158\/1078-0432.CCR-0349-03","article-title":"Use of replicating oncolytic adenoviruses in combination therapy for cancer","volume":"10","author":"Chu","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.022_bib14","first-page":"435","article-title":"Selectively replicating oncolytic adenoviruses as cancer therapeutics","volume":"4","author":"Yu","year":"2002","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group","volume":"87","author":"Bosch","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2009.09.022_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2009.09.022_bib17","first-page":"5019s","article-title":"Role of the human papillomaviruses in human cancer","volume":"51","author":"Howley","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.022_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2009.09.022_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/mthe.2001.0447","article-title":"Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes","volume":"4","author":"Steinwaerder","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib20","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2346::AID-CNCR14>3.0.CO;2-G","article-title":"Radiation-enhanced expression of E6\/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma","volume":"83","author":"Santin","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.09.022_bib21","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1158\/1078-0432.CCR-06-2704","article-title":"Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells","volume":"13","author":"Tang","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.022_bib22","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1158\/1078-0432.CCR-05-1085","article-title":"Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability","volume":"11","author":"Zhou","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.022_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/0-89603-551-4:25","article-title":"Isolation, growth, and purification of defective adenovirus deletion mutants","author":"Ketner","year":"1998","journal-title":"Adenov. Methods Protocols"},{"key":"10.1016\/j.canlet.2009.09.022_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10495-007-0163-8","article-title":"RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53","volume":"13","author":"Sima","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2009.09.022_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2007.04.039","article-title":"Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells","volume":"106","author":"Sima","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2009.09.022_bib26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1074\/jbc.271.3.1364","article-title":"Activation of the integrin alpha v beta 3 involves a discrete cation-binding site that regulates conformation","volume":"271","author":"Pelletier","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2009.09.022_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.cgt.7700024","article-title":"Development and application of adenoviral vectors for gene therapy of cancer","volume":"6","author":"Zhang","year":"1999","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1535-6108(02)00060-0","article-title":"Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents","volume":"1","author":"Johnson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2009.09.022_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.cgt.7700771","article-title":"Replication-selective oncolytic viruses in the treatment of cancer","volume":"12","author":"Everts","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ymthe.2005.12.009","article-title":"Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus","volume":"13","author":"Gao","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.cgt.7700967","article-title":"Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo","volume":"13","author":"Chen","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2009.09.022_bib32","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1101\/gad.12.15.2245","article-title":"The regulation of E2F by pRB-family proteins","volume":"12","author":"Dyson","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2009.09.022_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1535-6108(03)00080-1","article-title":"Emerging roles for E2F: beyond the G1\/S transition and DNA replication","volume":"3","author":"Cam","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2009.09.022_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0042-6822(89)90107-4","article-title":"Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers","volume":"172","author":"Matsukura","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2009.09.022_bib35","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.4161\/cc.6.16.4555","article-title":"E6\/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells","volume":"6","author":"Yasmeen","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2009.09.022_bib36","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00001622-199309000-00018","article-title":"Radiotherapy for gynecologic cancer","volume":"5","author":"Bertelsen","year":"1993","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canlet.2009.09.022_bib37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2004.07.003","article-title":"Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer","volume":"95","author":"Chen","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2009.09.022_bib38","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nrc1458","article-title":"A vision for the national cancer program in the United States","volume":"4","author":"von Eschenbach","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2009.09.022_bib39","first-page":"7464","article-title":"A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy","volume":"61","author":"DeWeese","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.022_bib40","first-page":"517","article-title":"Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel","volume":"61","author":"Yu","year":"2001","journal-title":"Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509006211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509006211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T11:28:24Z","timestamp":1544873304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383509006211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0304383509006211"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2009.09.022","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}